Trademark: 88360435
Word
MEGACBD
Status
Dead
Status Code
602
Status Date
Monday, August 16, 2021
Serial Number
88360435
Mark Type
4000
Filing Date
Thursday, March 28, 2019
Abandoned Date
Wednesday, July 28, 2021

Trademark Owner History

Classifications
5 IC 005. US 005 006 018 044 046 051 052. G and S: Herbal tinctures for medical purposes; Dietary and nutritional supplements for pets; Dietary and nutritional supplements in the form of tinctures, drops, capsules, oils, gummies, and powders; Topical analgesic creams, gels, salves, sprays, powders, and ointments; Topical anti-inflammatory creams, gels, salves, sprays, powders, and ointments; Topical medicated moisturizing creams, gels, salves, sprays, powders, and ointments; natural sleep aid preparations; any CBD in the all of the foregoing goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
"MEGA CBD" OR "CBD MEGA"
MEGA CBD

Trademark Events
Aug 16, 2021
Abandonment Notice E-Mailed - Failure To Respond
Aug 16, 2021
Abandonment - Failure To Respond Or Late Response
Aug 16, 2021
Assigned To Examiner
Jan 27, 2021
Notification Of Final Refusal Emailed
Jan 27, 2021
Final Refusal E-Mailed
Jan 27, 2021
Final Refusal Written
Jan 9, 2021
Teas/Email Correspondence Entered
Jan 9, 2021
Correspondence Received In Law Office
Jan 9, 2021
Teas Response To Office Action Received
Sep 3, 2020
Notification Of Non-Final Action E-Mailed
Sep 3, 2020
Non-Final Action E-Mailed
Sep 3, 2020
Non-Final Action Written
Aug 18, 2020
Teas/Email Correspondence Entered
Aug 18, 2020
Correspondence Received In Law Office
Aug 14, 2020
Assigned To Lie
Jul 28, 2020
Teas Response To Office Action Received
Mar 2, 2020
Notification Of Non-Final Action E-Mailed
Mar 2, 2020
Non-Final Action E-Mailed
Mar 2, 2020
Non-Final Action Written
Mar 2, 2020
Assigned To Examiner
Apr 24, 2019
Assigned To Examiner
Apr 15, 2019
New Application Office Supplied Data Entered In Tram
Apr 1, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24